Health and Fitness Health and Fitness
Fri, October 21, 2011
Thu, October 20, 2011
Wed, October 19, 2011
Tue, October 18, 2011
Mon, October 17, 2011
Sun, October 16, 2011
Sat, October 15, 2011
Fri, October 14, 2011
Thu, October 13, 2011
Wed, October 12, 2011
[ Wed, Oct 12th 2011 ] - Market Wire
Financial Statement 10/11
Tue, October 11, 2011
[ Tue, Oct 11th 2011 ] - Market Wire
Aetna??Michael Elliott???????
Mon, October 10, 2011
Sun, October 9, 2011
Sat, October 8, 2011
Fri, October 7, 2011
Thu, October 6, 2011
Wed, October 5, 2011
Tue, October 4, 2011
Mon, October 3, 2011

Incyte to Report Third Quarter 2011 Financial Results and Provide Update on Key Clinical Programs on October 27


//health-fitness.news-articles.net/content/2011/ .. date-on-key-clinical-programs-on-october-27.html
Published in Health and Fitness on Thursday, October 13th 2011 at 13:26 GMT by Market Wire   Print publication without navigation


WILMINGTON, Del.--([ BUSINESS WIRE ])--Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled its third quarter 2011 financial results conference call for 8:30 a.m. ET on Thursday, October 27, 2011. The schedules for the press release and conference call are as follows:

-- Q3 2011 Press Release: October 27, 2011 at 7:00 a.m. ET
-- Q3 2011 Conference Call: October 27, 2011 at 8:30 a.m. ET
-- Domestic Dial In Number: 877-407-8037
-- International Dial In Number: 201-689-8037
-- Conference ID # 380549

If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and dial-in number for international callers is 201-612-7415. To access the replay you will need the conference account number 278 and the ID number 380549.

The conference call will also be webcast live and can be accessed at [ www.incyte.com ] under Investor Relations, Events and Webcasts.

About Incyte

Incyte Corporation is a Wilmington, Delaware-based drug discovery and development company focused on developing proprietary small molecule drugs for oncology and inflammation. For additional information on Incyte, visit the Company's web site at [ www.incyte.com ].


Publication Contributing Sources